|
GFM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.9250004902367E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.66970004278744E-09 |
| Normal-vs-Stage2 |
1.484680E-03 |
| Normal-vs-Stage3 |
2.13869999999838E-05 |
| Normal-vs-Stage4 |
4.9349000441623E-09 |
| Stage1-vs-Stage2 |
8.962400E-01 |
| Stage1-vs-Stage3 |
6.562600E-01 |
| Stage1-vs-Stage4 |
2.356100E-02 |
| Stage2-vs-Stage3 |
6.100000E-01 |
| Stage2-vs-Stage4 |
1.031550E-01 |
| Stage3-vs-Stage4 |
2.100400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41720002400092E-09 |
| Normal-vs-AfricanAmerican |
4.70190000267934E-08 |
| Normal-vs-Asian |
2.716200E-01 |
| Caucasian-vs-AfricanAmerican |
6.153400E-01 |
| Caucasian-vs-Asian |
8.481200E-01 |
| AfricanAmerican-vs-Asian |
6.858200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.39439637193118E-11 |
| Normal-vs-Female |
4.426100E-04 |
| Male-vs-Female |
9.333800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.30969999999164E-05 |
| Normal-vs-Extreme_Weight |
4.28009849784416E-11 |
| Normal-vs-Obese |
8.39050000034369E-07 |
| Normal-vs-Extreme_Obese |
2.704800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.482600E-01 |
| Normal_Weight-vs-Obese |
8.504000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.428000E-01 |
| Extreme_Weight-vs-Obese |
3.578600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.224380E-01 |
| Obese-vs-Extreme_Obese |
3.559600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.86852999999321E-05 |
| Normal-vs-Age(41-60Yrs) |
7.47730000139057E-09 |
| Normal-vs-Age(61-80Yrs) |
2.30440000414944E-08 |
| Normal-vs-Age(81-100Yrs) |
1.580090E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.922600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.704600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.293000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.826400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.802200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.901200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.42599981506942E-10 |
| Normal-VS-Type2 PRCC |
3.377000E-04 |
| Normal-VS-KIRP CIMP |
2.20769999947912E-07 |
| Normal-VS-Unclassified PRCC |
6.241400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.772800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.374600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.496000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.353700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.932600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.824410E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.18409999477964E-08 |
| Normal-vs-N1 |
3.29649999997184E-06 |
| Normal-vs-N2 |
2.11139999999332E-05 |
| N0-vs-N1 |
7.353400E-01 |
| N0-vs-N2 |
3.480200E-01 |
| N1-vs-N2 |
4.113800E-01 |
|
|
